Skip to main content

Kynam Capital Management, LP's Form 4 filing

2seventy bio, Inc. (TSVT) · filed Mar 13, 2025

Accession no.
0000919574-25-001923
Filed
Mar 13, 2025, 6:18 PM ET
Trade date
Mar 11, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $80.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kynam Capital Management, LPCIK 000190788410% Owner
Kynam Capital Management GP, LLCCIK 000199003310% Owner
Kynam Global Healthcare Master Fund, LPCIK 000199010010% Owner
Kynam Fund GP, LLCCIK 000199017710% Owner
Tang YueCIK 000199022010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 11, 2025Common Stock, par value $0.0001 per shareSSaleDisposed−5,953,825$4.93−$29,352,357.250Indirect
Mar 11, 2025Common Stock, par value $0.0001 per shareSSaleDisposed−5,142,111$4.93−$25,350,607.230Direct
Mar 11, 2025Common Stock, par value $0.0001 per shareSSaleDisposed−5,142,111$4.93−$25,350,607.230Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)